Compass Group PLC
1 December 2004
Compass Group PLC wishes to notify the following changes in Directors' interests
in ordinary shares of 10 pence each in the share capital of the Company
('Shares').
Compass Group Share Option Plan (the 'Option Plan')
Directors of Compass Group PLC (the 'Company') were today granted for nil
consideration options under the terms of the Company's Option Plan over Shares
set out below.
Name Exercise Number of Normal Total
Price Options Exercise Number of
(pence) Granted Period Options Held
(from/to) Following
Grant
Sir Francis Henry Mackay 229.25 450,000 1 Dec 2007- 2,651,245
30 Nov 2014
Michael John Bailey 229.25 855,000 1 Dec 2007- 5,879,925
30 Nov 2014
Alain Francois Dupuis 229.25 390,000 1 Dec 2007- 2,435,000
30 Nov 2014
Clive William Patrick Grundy 229.25 390,000 1 Dec 2007- 2,285,553
30 Nov 2014
Andrew Patrick Lynch 229.25 460,000 1 Dec 2007- 2,930,178
30 Nov 2014
Andrew David Martin 229.25 365,000 1 Dec 2007- 1,018,532
30 Nov 2014
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.